Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...
FOX 5 New York on MSN6h
Sickle cell patient declared disease free after groundbreaking therapy on Long IslandA sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him ...
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...
By Deena Beasley (Reuters) -Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing ...
This approval was followed by Takeda Pharmaceuticals’ Alofisel (darvadstrocel), which received approval from the European Medicines Agency in 2018 and from Japan’s Pharmaceuticals and Medical Devices ...
Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...
The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...
In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...
He’s got new blood. A Long Island hospital said it administered life-changing Lyfgenia gene therapy treatment and successfully wiped away sickle cell disease from a Laurelton man. Cohen Children’s ...
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: ...
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback